Pharmaceutical companies in Nepal register trademarks through the Department of Industry under the Patent, Design and Trademark Act 1965. The process takes 12–14 months, covers one NICE class per application, and follows a first-to-file rule—rights go to the first valid applicant, not the first user.
Key Takeaways
- Nepal’s trademark system is first-to-file: the first valid application secures rights, not the first commercial use.
- Pharmaceutical brands typically file in NICE Class 5 (medicines) and Class 35 (distribution services).
- The Department of Industry examines applications, publishes them in the Industrial Property Bulletin, and allows a 90-day opposition window.
- Registration lasts 7 years and is renewable indefinitely; late renewal incurs a fine but can still be done within 6 months.
- Without registration, you risk copycats, blocked expansion, and no legal basis to stop infringers.
Why pharmaceutical companies register trademarks in Nepal
Pharmaceutical companies register trademarks in Nepal to protect their brand names, logos, and product lines from copycats. Under the Patent, Design and Trademark Act 1965, only registered marks give you the legal right to stop others from using identical or confusingly similar names on medicines, packaging, or promotional materials. Without registration, you risk losing your brand to a first-to-file competitor, facing blocked market expansion, and having no basis to act against infringers.
In practice, a registered trademark also builds trust with doctors, pharmacists, and patients. A mark with the ® symbol signals that the Department of Industry has examined and approved it, which can be a deciding factor in prescription decisions. For companies planning to franchise or license their brand, registration is a prerequisite—no licensee will invest in a brand that isn’t legally protected.
Which NICE classes apply to pharmaceutical companies in Nepal?
Pharmaceutical companies in Nepal typically file trademark applications in NICE Class 5 for medicines and Class 35 for distribution services. The Department of Industry uses the NICE Classification system, which divides goods and services into 45 classes. One application covers one class, so if your brand spans both goods and services, you need two separate applications.
Class 5 is the core class for pharmaceutical companies. It covers medicines, dietary supplements, veterinary products, disinfectants, and medical devices. If you sell a branded cough syrup, pain reliever, or vitamin supplement, Class 5 is where you file. Class 35 is for service-based aspects of your business—retail pharmacy services, wholesale distribution, and advertising. If you operate a chain of pharmacies under your brand name, you’ll need Class 35 to protect the service side of your business.
A common mistake we see is companies assuming one application covers both goods and services. It doesn’t. Each class requires its own application, its own set of documents, and its own government fee. If you’re unsure which classes apply to your brand, you can use the NICE Class Finder tool to map your products and services to the correct classes.
What kinds of marks do pharmaceutical companies protect?
Pharmaceutical companies in Nepal protect four main types of marks: brand names, logos and wordmarks, taglines, and product-line names. Each serves a different commercial purpose and faces different risks if left unregistered.
Brand names are the most critical. These are the names patients and doctors recognise—like “NepaCure” for a line of antibiotics or “Dhulikhel Pharma” for a regional manufacturer. A strong brand name becomes synonymous with quality and reliability, which is why copycats target it first. Without registration, another company can file for the same name and force you to rebrand, losing years of brand equity.
Logos and wordmarks are the visual identity of your brand. A distinctive logo—like a stylised mortar and pestle or a unique font for your brand name—helps patients identify your products on crowded pharmacy shelves. Wordmarks (text-only logos) are equally important; think of the way “Panadol” is presented in a specific font and colour. These marks are protected under the same trademark application as your brand name, provided they’re part of the same commercial identity.
Taglines are short, memorable phrases that reinforce your brand promise. Examples include “For a healthier tomorrow” or “Trusted by doctors since 2010.” While taglines are less likely to be copied outright, they can be diluted if competitors use similar phrases. Registering your tagline prevents this and gives you a basis to act if someone tries to ride on your brand’s reputation.
Product-line names are the names you give to specific product ranges. For example, “NepaCure Cold & Flu” or “Dhulikhel Pharma Diabetic Care.” These names help patients and doctors navigate your product portfolio. Without registration, a competitor can launch a similar-sounding product and confuse the market, potentially diverting sales and harming your brand’s integrity.
How to register a pharmaceutical trademark in Nepal: step-by-step
Registering a pharmaceutical trademark in Nepal involves five key steps: filing the application, Department of Industry examination, publication in the Industrial Property Bulletin, a 90-day opposition window, and issuance of the registration certificate. Here’s how each step works in practice.
- File the application
You start by filing an application with the Department of Industry. The application must include the mark you want to register (brand name, logo, or both), the NICE class(es) you’re filing in, and the list of goods or services the mark will cover. For pharmaceutical companies, this usually means Class 5 for medicines and Class 35 for distribution services. You’ll also need to submit four specimens of the mark—these can be digital images of your logo or product packaging.
Foreign companies must file through a Nepal-based agent or representative, as the Department of Industry does not accept direct applications from abroad. The agent will need a notarised Power of Attorney, a board resolution from your company, and a certified copy of your home-country trademark registration if you’re claiming priority under the Paris Convention.
- Department of Industry examination
Once filed, the Department of Industry examines your application for distinctiveness and conflicts with existing marks. The examiner checks whether your mark is too similar to a mark already registered in the same class. For pharmaceutical companies, this is especially important because drug names must not be confusingly similar to existing medicines—this could pose a public health risk and lead to rejection.
If the examiner finds an issue, they’ll issue an objection. You’ll have a chance to respond and argue why your mark should be accepted. Common objections for pharmaceutical marks include similarity to an existing drug name or lack of distinctiveness (for example, if your mark is just a generic term like “Pain Relief”).
- Publication in the Industrial Property Bulletin
If your application passes examination, the Department of Industry publishes it in the Industrial Property Bulletin. This is a public notice that gives third parties a chance to oppose your registration. The Bulletin is published periodically, and the 90-day opposition window starts from the date of publication.
During this period, anyone who believes your mark infringes on their rights can file an opposition. For pharmaceutical companies, oppositions often come from competitors who claim your mark is too similar to theirs or from companies that believe your mark could mislead patients or doctors.
- 90-day opposition window
The 90-day opposition window is a critical phase. If someone files an opposition, the Department of Industry will notify you, and you’ll have a chance to respond. The DoI acts as a quasi-judicial body during this phase, holding hearings and reviewing evidence from both sides. If the opposition is successful, your application will be rejected. If it’s unsuccessful, or if no opposition is filed, your application moves to the final stage.
In practice, most pharmaceutical trademark applications are unopposed. However, if your mark is similar to a well-known brand or a generic term, you’re more likely to face opposition. This is why it’s important to conduct a thorough trademark search before filing—you can use the Trademark Conflict Checker to identify potential conflicts early.
- Issuance of the registration certificate
If your application is unopposed or if you successfully defend against an opposition, the Department of Industry will issue your registration certificate. This certificate is your legal proof of ownership, and it allows you to use the ® symbol with your mark. The registration is valid for 7 years from the date of registration and can be renewed indefinitely for further 7-year terms.
Once registered, you can take legal action against anyone who uses your mark without permission. This includes competitors who try to sell counterfeit versions of your products or who use a similar name to confuse patients and doctors.
Documents needed for pharmaceutical trademark registration
Pharmaceutical companies in Nepal need six core documents to register a trademark: the application form, a notarised Power of Attorney, a board resolution, specimens of the mark, a tax clearance certificate, and an industry registration certificate. Foreign companies must also provide a certified copy of their home-country trademark registration if claiming priority.
The application form is straightforward—it lists your company details, the mark you want to register, and the NICE class(es) you’re filing in. The Power of Attorney must be notarised and signed by an authorised representative of your company. If you’re a foreign company, this document must also be attested by two witnesses. The board resolution confirms that your company has authorised the trademark application and names the person or agent who will act on its behalf.
You’ll also need to submit four specimens of the mark. These can be digital images of your logo, product packaging, or promotional materials. The specimens must clearly show how the mark will be used in commerce. For pharmaceutical companies, this often means images of medicine packaging, labels, or signage from your pharmacies or clinics.
Domestic companies must provide a tax clearance certificate and an industry registration certificate. These documents prove that your company is legally registered and up to date on its tax obligations. Foreign companies don’t need these but must provide a certified copy of their home-country trademark registration if they’re claiming priority under the Paris Convention. This document must be notarised and translated into English if it’s in another language.
Timeline for pharmaceutical trademark registration in Nepal
Pharmaceutical trademark registration in Nepal typically takes 12–14 months from filing to certificate. The Department of Industry’s examination phase takes 4–6 months, publication in the Industrial Property Bulletin adds another 1–2 months, and the 90-day opposition window brings the total to about a year. In the smoothest cases—where there are no objections or oppositions—the process can be completed in 6–8 months.
The timeline can vary depending on several factors. If the Department of Industry issues an objection, you’ll need time to respond, which can add 2–3 months to the process. Similarly, if someone files an opposition, the DoI will hold hearings and review evidence, which can extend the timeline by 3–6 months. Delays can also occur if your application is incomplete or if the DoI is backlogged—this is why it’s important to file a complete, accurate application from the start.
Once your mark is registered, it’s valid for 7 years. You can renew it indefinitely for further 7-year terms, but you must file the renewal application within 35 days of the expiry date. If you miss this window, you have a 6-month grace period to renew with a late fee. After that, your registration is automatically cancelled, and you’ll need to file a new application if you want to protect your mark.
Cost factors for pharmaceutical trademark registration in Nepal
The cost of registering a pharmaceutical trademark in Nepal depends on three main factors: the number of NICE classes you file in, government fees, and professional service fees. Each class requires a separate application, so if you file in both Class 5 (medicines) and Class 35 (distribution services), you’ll pay twice the government fee. Government fees are set by the Department of Industry and cover the cost of examination, publication, and registration.
Professional service fees vary depending on the complexity of your application. If your mark is straightforward and doesn’t face objections or oppositions, the process will be less expensive. If you need to respond to an objection or defend against an opposition, the cost will be higher. Foreign companies also pay higher fees because they must file through a Nepal-based agent, who charges for their services.
To get a precise estimate, you can use the Trademark Fee Calculator. This tool lets you select the number of classes, whether you’re a domestic or foreign applicant, and whether you expect any objections or oppositions. It will then give you a breakdown of the costs involved. Keep in mind that this is an estimate—actual costs may vary depending on the specifics of your application.
Legal basis for pharmaceutical trademark registration in Nepal
Pharmaceutical trademark registration in Nepal is governed by the Patent, Design and Trademark Act 1965. This Act defines what a trademark is, how it’s registered, and what rights it confers. Under Sec. 2(c) of the Act, a trademark is a word, symbol, picture, or combination used to distinguish a company’s products or services from others. Sec. 16(1) states that title to a trademark is acquired only upon registration with the Department of Industry.
The Act also sets out the grounds for refusal. Sec. 18(1) prohibits the registration of marks that hurt public morality, damage another’s goodwill, or are already registered in someone else’s name. For pharmaceutical companies, this means your mark must not be too similar to an existing drug name or generic term. The Act also requires that marks be used within 1 year of registration—if you don’t use your mark, the Department of Industry can cancel it under Sec. 18C.
Nepal is a signatory to the Paris Convention and TRIPS, which means foreign companies can claim priority for their trademark applications if they’vefiled in another member country within the last 6 months. This is particularly useful for pharmaceutical companies expanding into Nepal, as it allows you to secure your brand name without losing priority to a local competitor. However, Nepal is not part of the Madrid System or the PCT, so foreign applicants must file directly through a Nepal-based agent.
Risks of not registering a pharmaceutical trademark in Nepal
Not registering your pharmaceutical trademark in Nepal exposes your brand to four major risks: copycats, blocked expansion, loss of brand equity, and no legal recourse against infringers. Without registration, you have no legal right to stop another company from using your brand name, logo, or product names. This is especially dangerous in the pharmaceutical sector, where counterfeit or lookalike products can pose serious health risks to patients.
Copycats are the most immediate threat. If you don’t register your mark, another company can file for the same name and force you to rebrand. This isn’t just a theoretical risk—we’ve seen cases where a local manufacturer filed for a well-known international drug name and began selling a generic version under that brand. The original company had no legal basis to stop them because they hadn’t registered their mark in Nepal. Rebranding is expensive and disruptive, especially for pharmaceutical companies that have spent years building trust with doctors and patients.
Blocked expansion is another risk. If you plan to franchise your brand or open new pharmacies under your name, you’ll need a registered trademark. Franchisees and investors won’t commit to a brand that isn’t legally protected, and landlords may hesitate to lease space to a business with an unregistered name. Without registration, you also can’t license your brand to other companies, which limits your revenue streams and growth potential.
Loss of brand equity is a long-term risk. A strong pharmaceutical brand represents years of investment in research, quality control, and marketing. If a competitor uses your name or a similar one, they can dilute your brand’s reputation and erode patient trust. This is particularly damaging in the pharmaceutical sector, where trust is everything. Patients and doctors need to be confident that the medicine they’re prescribing or taking is from a reputable source. A copycat product can undermine that confidence and harm your brand’s long-term value.
Finally, without registration, you have no legal recourse against infringers. The Patent, Design and Trademark Act 1965 only protects registered marks. If someone copies your brand, you can’t take legal action to stop them or claim damages. This leaves you powerless to protect your brand, even if the infringement is blatant. In contrast, a registered trademark gives you the legal basis to sue for infringement, seek injunctions, and recover damages.
A realistic Nepal example: protecting a pharmaceutical brand
Let’s consider a realistic example: a Kathmandu-based pharmaceutical company, “Himalayan Remedies,” wants to register its brand name and logo for a new line of diabetes medications. The company has been selling its products under the name “Himalayan GlucoCare” for two years but hasn’t registered the trademark. Recently, it noticed a competitor selling a similar product under the name “Himalayan GlucoCure,” which is causing confusion among patients and doctors.
Himalayan Remedies decides to register its trademark to protect its brand. It files two applications: one in NICE Class 5 for the diabetes medication and another in Class 35 for its retail pharmacy services. The company submits the required documents—a notarised Power of Attorney, a board resolution, specimens of the logo, and its industry registration certificate. It also conducts a trademark search using the Trademark Conflict Checker to ensure no one else has registered a similar mark.
The Department of Industry examines the applications and finds no conflicts. The marks are published in the Industrial Property Bulletin, and the 90-day opposition window begins. No one files an opposition, so the DoI issues the registration certificates. Himalayan Remedies can now use the ® symbol with its brand name and logo, and it has the legal right to stop the competitor from using “Himalayan GlucoCure.”
This example illustrates why registration is critical. Without it, Himalayan Remedies would have no legal basis to stop the competitor, and its brand’s reputation could be permanently damaged. With registration, it can protect its investment, maintain patient trust, and expand its business with confidence.
Common mistakes pharmaceutical companies make when registering trademarks
Pharmaceutical companies in Nepal often make three common mistakes when registering trademarks: filing in the wrong NICE class, not conducting a thorough trademark search, and waiting too long to file. These mistakes can lead to rejections, oppositions, or even legal disputes, all of which delay registration and increase costs.
Filing in the wrong NICE class is the most frequent error. Many companies assume one application covers all their products and services, but Nepal’s system requires a separate application for each class. For example, if you sell medicines (Class 5) and operate pharmacies (Class 35), you need two applications. Filing in the wrong class can result in your application being rejected or, worse, your mark being unprotected in the classes that matter most. To avoid this, use the NICE Class Finder to map your products and services to the correct classes.
Not conducting a thorough trademark search is another common mistake. Many companies file an application without checking whether their mark is already registered or too similar to an existing one. This can lead to objections from the Department of Industry or oppositions from third parties. A trademark search helps you identify potential conflicts before you file, saving you time and money. You can use the Trademark Conflict Checker to search the DoI’s database for existing marks.
Waiting too long to file is a third mistake. Nepal follows a first-to-file rule, which means the first valid application secures the rights, not the first commercial use. If you wait to file, another company can register your mark and block you from using it. This is especially risky for pharmaceutical companies, where brand names are often the most valuable asset. The sooner you file, the sooner you secure your rights and protect your brand from copycats.
Alternatives and edge cases for pharmaceutical trademark registration
While most pharmaceutical companies register their trademarks in NICE Class 5 and Class 35, there are alternatives and edge cases to consider. For example, if your company conducts clinical trials or scientific research, you may also want to file in Class 42 for laboratory services. If you sell medical devices, Class 10 might apply. Some companies also file in Class 44 for healthcare services, though this is less common for pharmaceutical brands.
Another edge case is the registration of generic or descriptive terms. Under the Patent, Design and Trademark Act 1965, marks that are purely descriptive or generic cannot be registered. For example, you can’t register “Pain Relief” as a trademark for a painkiller because it describes the product’s function. However, you can register a distinctive brand name like “NepaCure Pain Relief” if the “NepaCure” element is unique and not descriptive. The key is to ensure your mark has a distinctive element that sets it apart from generic terms.
Foreign companies face additional considerations. If you’re expanding into Nepal from another country, you can claim priority under the Paris Convention if you file within 6 months of your home-country application. This allows you to backdate your Nepal filing date to your original application date, which can be crucial in a first-to-file system. However, you must file through a Nepal-based agent and provide a certified copy of your home-country registration. If you miss the 6-month window, you’ll need to file a new application in Nepal, which may be at risk if a local competitor has already filed for a similar mark.
Finally, some pharmaceutical companies consider registering their marks as industrial designs if they have unique packaging or product shapes. While this is possible, it’s important to note that industrial designs protect the visual appearance of a product, not its brand name or logo. If you want to protect both, you’ll need to file separate applications for trademarks and industrial designs.
In short
- Pharmaceutical companies in Nepal register trademarks to protect brand names, logos, taglines, and product-line names from copycats and infringers.
- The process takes 12–14 months and involves filing, examination, publication, a 90-day opposition window, and registration.
- Most pharmaceutical brands file in NICE Class 5 (medicines) and Class 35 (distribution services), with each class requiring a separate application.
- Without registration, you risk losing your brand to a first-to-file competitor, facing blocked expansion, and having no legal basis to stop infringers.
- Common mistakes include filing in the wrong class, not conducting a trademark search, and waiting too long to file.
- Foreign companies can claim priority under the Paris Convention but must file through a Nepal-based agent.
People also search for
- How to register a trademark in Nepal step by step
- How long does trademark registration take in Nepal?
- How to choose the right trademark class in Nepal
- What is NICE Class 5 for pharmaceuticals in Nepal?
- How foreign pharmaceutical companies register trademarks in Nepal
- What is NICE classification and how do trademark classes work?
- How to renew a pharmaceutical trademark in Nepal
- How to oppose a pharmaceutical trademark in Nepal
Ready to protect your pharmaceutical brand? Start with a trademark search to check for conflicts, or contact us for a consultation. Use the NICE Class Finder to map your products and services to the correct classes, and the Trademark Fee Calculator to estimate your costs.






Comments (0)
Leave a comment
Replying to — cancel